This multi-year exclusive partnership is designed to expand access to Harrow’s ophthalmic branded products, including FLAREX®, ILEVRO®, MAXIDEX®, MAXITROL®, NATACYN®, NEVANAC®, TOBRADEX ...

According to IQVIA, sales data for the 12-month period ending December 2024, the Xalatan Ophthalmic Solution achieved annual sales of around USD 113.5 million. Glenmark Pharmaceuticals on Friday ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of latanoprost ophthalmic solution, 0.005% (0.05 mg/mL). Glenmark’s latanoprost ophthalmic solution, 0.005% (0.05 mg/mL) is ...

Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and ...

(RTTNews) - Glenmark Pharmaceuticals Ltd. (GLENMARK.NS), Friday announced that it has introduced Latanoprost Ophthalmic Solution, 0.005 percent, a bioequivalent and therapeutically equivalent ...

Inc., USA (Glenmark) has announced the launch of Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), further strengthening ...

2008). The following are safe ophthalmic preparations: Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox® ophthalmic solution (moxifloxacin), Ocuflox® ophthalmic solution ...

Glenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. The product matches Upjohn US LLC's Xalatan Ophthalmic ...

30 days Prescribing information Latanoprost 0.005% ophthalmic solution Xalatan (Pharmacia and Upjohn) 6 wk Prescribing information Lopinavir/ritonavir capsules Kaletra capsules (Abbott ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF ... at £470 for one vial of 7.5 mg per 0.3 ml solution – is "similar to the cost of aflibercept." ...

ORLANDO — In this Healio Video Perspective from Telling It Like It Is, Cynthia Matossian, MD, FACS, shared pearls for ophthalmologists who want to take part in clinical trials. A one-time ...

Glenmark Pharmaceuticals Inc, USA has launched Latanoprost ophthalmic solution, 0.005% (0.05 mg/mL) in the market, the Mumbai-based drug maker said in a statement. The company’s product is ...